文献速递消化系统肿瘤

逆转录酶抑制破坏结直肠癌重复元件生命周期

Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer.
PubMed 文献 · Cancer Discov · 2022-01-01

研究显示核苷类逆转录酶抑制剂3TC在结直肠癌临床前模型中靶向重复元件活性,对p53突变细胞系作用更明显,并与p53直接结合重复元件相关;转移性结直肠癌单药II期试验中32例有9例临床获益,肿瘤球出现免疫原性RNA:DNA杂交体蓄积及干扰素反应和DNA损伤反应。

要点

  • 3TC在结直肠癌临床前模型中靶向重复元件活性,对p53突变细胞系作用更明显。
  • 转移性结直肠癌单药3TC的II期试验中,32例患者有9例临床获益。
  • 3TC使肿瘤球中免疫原性RNA:DNA杂交体蓄积,伴干扰素反应基因和DNA损伤反应诱导。

核心结论

  • 靶向重复元件的病毒模拟是结直肠癌的一个易感点,核苷类逆转录酶抑制剂可诱导DNA损伤和干扰素反应,提供新的抗癌治疗策略。

研究设计与样本

  • 临床前结直肠癌模型研究,以及转移性结直肠癌患者单药3TC治疗的II期人体试验,共32例。

主要发现

  • 3TC在结直肠癌临床前模型中靶向重复元件活性,对p53突变细胞系作用更明显,并与p53直接结合重复元件相关。
  • 转移性结直肠癌单药3TC的II期试验中,32例患者有9例临床获益。
  • 3TC处理结直肠癌肿瘤球后,免疫原性RNA:DNA杂交体蓄积,伴干扰素反应基因诱导和DNA损伤反应。
  • 表观遗传药物和DNA损伤药物诱导重复RNA,与3TC联用时细胞毒性增强。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Altered RNA expression of repetitive sequences and retrotransposition are frequently seen in colorectal cancer, implicating a functional importance of repeat activity in cancer progression. We show the nucleoside reverse transcriptase inhibitor 3TC targets activities of these repeat elements in colorectal cancer preclinical models with a preferential effect in p53-mutant cell lines linked with direct binding of p53 to repeat elements. We translate these findings to a human phase II trial of single-agent 3TC treatment in metastatic colorectal cancer with demonstration of clinical benefit in 9 of 32 patients. Analysis of 3TC effects on colorectal cancer tumorspheres demonstrates accumulation of immunogenic RNA:DNA hybrids linked with induction of interferon response genes and DNA damage response. Epigenetic and DNA-damaging agents induce repeat RNAs and have enhanced cytotoxicity with 3TC. These findings identify a vulnerability in colorectal cancer by targeting the viral mimicry of repeat elements. SIGNIFICANCE: Colorectal cancers express abundant repeat elements that have a viral-like life cycle that can be therapeutically targeted with nucleoside reverse transcriptase inhibitors (NRTI) commonly used for viral diseases. NRTIs induce DNA damage and interferon response that provide a new anticancer therapeutic strategy. This article is highlighted in the In This Issue feature, p. 1397.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Rajurkar M, Parikh AR, Solovyov A, et al. Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer. Cancer Discov. 2022. PMID: 35320348. doi:10.1158/2159-8290.CD-21-1117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。